Hyundai Pharm (004310) — Long-term Investment Intensity

Latest as of November 2013: 4.1%

Hyundai Pharm (004310) has a Long-term Investment Intensity of 4.1% as of November 2013. Long-term investments of ₩5.83 Billion represent 4.1% of total assets of ₩143.40 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check asset resilience ratio of Hyundai Pharm to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

4.1%
LT Investments / Total Assets

Long-term Investments

₩5.83 Billion
KRW

Total Assets

₩143.40 Billion
KRW

Country

Korea
KO

Hyundai Pharm Long-term Investment Intensity (2010–2013)

This chart shows how Hyundai Pharm's Long-term Investment Intensity has evolved across 4 annual periods from 2010 to 2013. As of November 2013, the intensity stands at 4.1%, reflecting long-term investments of ₩5.83 Billion against total assets of ₩143.40 Billion KRW. For the complete balance sheet picture, see Hyundai Pharm total assets.

Annual Long-term Investment Intensity for Hyundai Pharm (2010–2013)

The table below presents the year-by-year Long-term Investment Intensity for Hyundai Pharm from 2010 to 2013, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 004310 liabilities breakdown for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2013 4.1% ₩5.83 Billion ₩143.40 Billion ▲ +0.4 pp
2012 3.7% ₩5.47 Billion ₩149.90 Billion ▲ +1.2 pp
2011 2.4% ₩3.80 Billion ₩156.95 Billion ▼ -3.2 pp
2010 5.6% ₩7.32 Billion ₩130.98 Billion
pp = percentage points